Developer docs
API playgroundTry for free, no card

Search company profiles

BeSound

Full company profile

uuid003q9bk

Namestring
BeSound
Legal namestring
BLOCH Quantum Imaging Solutions, Inc.
Company typeenum
Private
Founded yearint
2025
Descriptiontext

BeSound (legal entity: BLOCH Quantum Imaging Solutions, Inc.) is a Los Angeles-based breast imaging company founded in 2025 by Bailey Renger, a former NASA quantum physicist, and CTO John Stanco. The company operates direct-to-consumer breast cancer screening clinics using FDA-approved photoacoustic ultrasound technology combined with proprietary AI-based image analysis, targeting women seeking supplemental screening beyond or as an alternative to mammography.

The core product is a 15-minute breast imaging scan. The underlying technology uses photoacoustic ultrasound — laser-induced detection of blood oxygenation patterns associated with tumor angiogenesis — augmented by an AI layer that assists in interpreting imaging data and identifying suspicious findings. The service is positioned as a supplemental screening modality rather than a replacement for mammography, with reported sensitivity improvements over mammography alone.

BeSound's business model is a retail clinical hybrid: company-owned physical clinics selling directly to consumers at $350 per scan on a self-pay basis, with select insurance providers also accepted. The company launched commercially in October 2025 with two Los Angeles locations (West Hollywood and Santa Monica). Growth levers include geographic expansion (New York targeted for early 2026), a planned mobile imaging van to broaden reach without fixed real estate, and selection into the Muse Capital Optima Program (April 2026). The $6.8M seed round was co-led by Overwater Ventures, Kindred Ventures, and Muse Capital.

Short descriptiontext

BeSound is a Los Angeles-based, direct-to-consumer breast imaging company that operates retail clinics using FDA-approved photoacoustic ultrasound with AI-assisted detection, selling $350 self-pay scans to women seeking supplemental breast cancer screening.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
breast imaging services, medical diagnostic imaging, photoacoustic ultrasound, AI cancer detection, women's health screening
Industry2 codes
PRIMARYHLAFAJAJ
Women’s Imaging & Breast Health Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Breast Imaging Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Direct-to-Consumer Breast Imaging Scans
TypeOne Time License
Description

Self-pay patients pay $350 per scan at time of booking via the BeSound app/website. Some provider partners (e.g., Ian Grady MD) accept insurance, creating a secondary reimbursement channel. BeSound operates a dual model: one provider group (Agape) does not accept insurance (self-pay only), while another (MD) accepts insurance.

besoundbreast.com
2Insurance-Reimbursed Imaging
TypeTransaction Fee
Description

For patients whose insurance is accepted by provider partner Ian Grady MD, BeSound submits claims to insurers on behalf of the provider. Patients are responsible for co-payments, co-insurance, or deductibles. Federal healthcare programs (Medicare, Medicaid) are not accepted.

besoundbreast.com
3Free Risk Assessment (Lead Generation)
TypeFreemium
Description

Free Tyrer-Cuzick risk assessment tool drives patient acquisition and risk-stratification intake, funneling higher-risk patients into paid screening ultrasound appointments.

besoundbreast.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Self-pay screening ultrasound scan at $350 per appointment
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$350 per scan for self-pay patients. Payment processed at booking or on the day of service depending on selected payment method. Prepaid payment methods charge immediately at booking.

besoundbreast.com
2Insurance-covered scan through in-network provider
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

For patients with accepted insurance plans (via Ian Grady MD provider), BeSound bills the insurer. Patient is responsible for co-payment, co-insurance, or deductible. Medicare and Medicaid are not accepted.

besoundbreast.com
3Free breast cancer risk assessment
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free Tyrer-Cuzick breast cancer risk quiz available to all users. Results based on clinically validated model. No charge for the assessment; drives patient funnel into paid scans.

besoundbreast.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

BeSound delivers radiation-free breast imaging using FDA-approved photoacoustic ultrasound (near-infrared light combined with traditional ultrasound) enhanced by AI-powered detection, sold direct-to-consumer at $350 per scan for women with dense breast tissue and women under 40. The platform also includes a free Tyrer-Cuzick breast cancer risk assessment, a self-serve patient web app for booking and results, and operates BeSound-branded retail locations in Los Angeles plus a forthcoming mobile van, while connecting patients with independent partner medical groups that provide licensed clinical interpretation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Detects 35.7% more breast cancers than mammography alone
+7 more records
Product overview1 text field

BeSound is a modern breast imaging company offering a technology platform that connects individuals with independent partner medical groups providing breast imaging services. The core offering is FDA-approved advanced ultrasound (ABUS/photoacoustic) breast screening combined with AI-powered detection, positioned as an alternative to mammography for women with dense breast tissue and women under 40. The platform includes a patient portal (app.besoundbreast.com) for appointment booking and results viewing, a free Tyrer-Cuzick risk assessment tool, and operates physical locations in Los Angeles with mobile unit services coming soon. The company was founded in October 2025 by former NASA quantum physicist Bailey Renger and has raised $6.8M in seed funding.

Product and service3 records
1BeSound Breast Imaging
CategoryBreast imaging / women's health diagnostics
Description

Radiation-free, pain-free 20-minute breast imaging scan using FDA-approved photoacoustic ultrasound combined with AI-powered detection, designed for women with dense breast tissue and women under 40, with results delivered in 24-48 hours through the patient dashboard.

2BeSound Risk Assessment (Tyrer-Cuzick)
CategoryBreast cancer risk assessment / patient intake tool
Description

Free, clinically validated Tyrer-Cuzick breast cancer risk quiz that calculates individualized 10-year and lifetime risk estimates and funnels higher-risk users into paid BeSound screening appointments.

3BeSound Patient App & Web Portal
CategoryPatient-facing digital platform
Description

Self-serve web application for booking appointments, completing intake and risk assessments, accessing scan results through a results dashboard, and managing waitlist and account activity.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-08
Description

BeSound was selected as one of ten women's health companies in Muse Capital's Optima Program — the first scalable health and performance platform designed for elite female athletes and sports executives, launched in partnership with Flywheel Ventures Group (providing technology) and the Red Bull Italy SailGP Team as part of SailGP's Impact League initiative. The program offers 360-degree physical and mental health support through science-backed solutions, positioning BeSound in the sports health ecosystem.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-08
Description

Red Bull Italy SailGP Team is a partner in SailGP's Impact League initiative, collaborating with Muse Capital and Flywheel Ventures on the Optima Program that includes BeSound among its ten selected women's health companies. The partnership brings athletic performance expertise and sports science network to the women's health ecosystem.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Agape Medical Group is a professional services corporation and provider partner that delivers clinical breast imaging services through BeSound's platform. Agape does not accept health insurance and operates on a self-pay model. BeSound provides the imaging technology and administrative platform; Agape provides licensed physicians, sonographers, and radiology reads.

4Ian Grady, MD, FACS
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Ian Grady MD FACS is a provider partner who accepts certain in-network insurance plans, offering an insurance-billed pathway for patients whose coverage is accepted. BeSound schedules patients with MD when they have accepted insurance. MD reads ultrasound images and provides clinical services.

besoundbreast.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Northern Valley Breast Clinic (NVBC) is referenced in the HIPAA Notice of Privacy Practice as a licensed physician and radiologist affiliate providing breast imaging interpretation services. Patients with accepted insurance through NVBC are directed to that provider's Notice of Privacy Practice.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Siemens Healthineers is a global medical imaging leader with mammography and ultrasound product lines. Comparable to BeSound as a broad incumbent in the breast imaging modality space with the resources to launch competing dense-breast screening offerings if the category gains traction.

TypeBroad incumbent
Description

Hologic is the dominant incumbent in mammography (3D tomosynthesis) and broader women's health imaging and diagnostics. Comparable as the legacy breast imaging category leader whose installed base and hospital relationships represent the competitive incumbent against BeSound's DTC ultrasound offering.

TypeBroad incumbent
Description

GE HealthCare is a global medical imaging incumbent with a substantial mammography and women's health portfolio. Comparable as a broad incumbent whose R&D scale, distribution channels, and existing dense-breast screening offerings position it as the most credible large-scale competitive threat to BeSound.

TypeDirect peer
Description

Ezra is a direct-to-consumer full-body MRI startup offering pay-out-of-pocket cancer and disease screening scans in retail locations. Highly comparable to BeSound in DTC premium imaging business model, retail location strategy, and self-pay price-transparent positioning targeting proactive health-conscious consumers.

TypeEmerging player
Description

Neko Health is a DTC preventive body-scanning startup offering AI-augmented full-body imaging in a premium consumer retail experience. Comparable to BeSound in DTC premium imaging business model, AI-driven diagnostics, and consumer-brand-led approach to preventive screening.

TypeDirect peer
Description

QT Ultrasound develops and operates FDA-cleared transmission ultrasound breast imaging as a radiation-free alternative to mammography. Directly comparable to BeSound as a breast ultrasound modality competitor focused on dense-breast and supplemental screening applications.

TypeDirect peer
Description

Delphinus developed SoftVue, an FDA-cleared automated whole-breast ultrasound system for supplemental dense-breast screening. A modality peer to BeSound's photoacoustic ultrasound, targeting the same clinical gap in dense-breast cancer detection.

TypeEmerging player
Description

iCAD provides AI-powered breast imaging analytics (ProFound AI for DBT) and risk-stratification solutions used alongside mammography. Comparable to BeSound as a technology peer in AI-driven breast imaging interpretation, though operating as a vendor to incumbent imaging centers rather than a DTC operator.

TypeDirect peer
Description

Prenuvo is a DTC whole-body MRI screening startup emphasizing early cancer detection in a premium, wellness-oriented consumer experience. Closely comparable to BeSound on DTC imaging business model, premium self-pay pricing, retail storefront delivery, and proactive-health positioning for an affluent consumer base.

TypeEmerging player
Description

SonoCiné provides automated whole-breast ultrasound systems (AWBUS) deployed in clinics as a supplemental screening modality for dense breast tissue. Comparable to BeSound in targeting the dense-breast screening gap with ultrasound-based technology, though distributed through partner clinics rather than DTC.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BeSound

Breast Imaging Servicesbesoundbreast.com

BeSound is a Los Angeles-based, direct-to-consumer breast imaging company that operates retail clinics using FDA-approved photoacoustic ultrasound with AI-assisted detection, selling $350 self-pay scans to women seeking supplemental breast cancer screening.

What BeSound does

BeSound (legal entity: BLOCH Quantum Imaging Solutions, Inc.) is a Los Angeles-based breast imaging company founded in 2025 by Bailey Renger, a former NASA quantum physicist, and CTO John Stanco. The company operates direct-to-consumer breast cancer screening clinics using FDA-approved photoacoustic ultrasound technology combined with proprietary AI-based image analysis, targeting women seeking supplemental screening beyond or as an alternative to mammography.

The core product is a 15-minute breast imaging scan. The underlying technology uses photoacoustic ultrasound — laser-induced detection of blood oxygenation patterns associated with tumor angiogenesis — augmented by an AI layer that assists in interpreting imaging data and identifying suspicious findings. The service is positioned as a supplemental screening modality rather than a replacement for mammography, with reported sensitivity improvements over mammography alone.

BeSound's business model is a retail clinical hybrid: company-owned physical clinics selling directly to consumers at $350 per scan on a self-pay basis, with select insurance providers also accepted. The company launched commercially in October 2025 with two Los Angeles locations (West Hollywood and Santa Monica). Growth levers include geographic expansion (New York targeted for early 2026), a planned mobile imaging van to broaden reach without fixed real estate, and selection into the Muse Capital Optima Program (April 2026). The $6.8M seed round was co-led by Overwater Ventures, Kindred Ventures, and Muse Capital.

BeSound firmographics

Firmographics
Name
BeSound
Legal name
BLOCH Quantum Imaging Solutions, Inc.
Website
https://besoundbreast.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
11–50 employees
Short description
BeSound is a Los Angeles-based, direct-to-consumer breast imaging company that operates retail clinics using FDA-approved photoacoustic ultrasound with AI-assisted detection, selling $350 self-pay scans to women seeking supplemental breast cancer screening.
Ownership category
akta.pro rank

BeSound industry classification

Industry
Product category
Breast Imaging Services
NAICS
Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAJAJ
Women’s Imaging & Breast Health Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Breast imaging services
  • Medical diagnostic imaging
  • Photoacoustic ultrasound
  • AI cancer detection
  • Women's health screening

Where BeSound is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices4 records

Markets served

BeSound business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Direct-to-Consumer Breast Imaging Scans: Self-pay patients pay $350 per scan at time of booking via the BeSound app/website. Some provider partners (e.g., Ian Grady MD) accept insurance, creating a secondary reimbursement channel. BeSound operates a dual model: one provider group (Agape) does not accept insurance (self-pay only), while another (MD) accepts insurance.
  2. Insurance-Reimbursed Imaging: For patients whose insurance is accepted by provider partner Ian Grady MD, BeSound submits claims to insurers on behalf of the provider. Patients are responsible for co-payments, co-insurance, or deductibles. Federal healthcare programs (Medicare, Medicaid) are not accepted.
  3. Free Risk Assessment (Lead Generation): Free Tyrer-Cuzick risk assessment tool drives patient acquisition and risk-stratification intake, funneling higher-risk patients into paid screening ultrasound appointments.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goSelf-pay screening ultrasound scan at $350 per appointment
Transaction based/ take ratePay-as-you-goInsurance-covered scan through in-network provider
FreemiumPay-as-you-goFree breast cancer risk assessment

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

BeSound product offering

Product offering

Core offering

BeSound delivers radiation-free breast imaging using FDA-approved photoacoustic ultrasound (near-infrared light combined with traditional ultrasound) enhanced by AI-powered detection, sold direct-to-consumer at $350 per scan for women with dense breast tissue and women under 40. The platform also includes a free Tyrer-Cuzick breast cancer risk assessment, a self-serve patient web app for booking and results, and operates BeSound-branded retail locations in Los Angeles plus a forthcoming mobile van, while connecting patients with independent partner medical groups that provide licensed clinical interpretation.

Product overview

BeSound is a modern breast imaging company offering a technology platform that connects individuals with independent partner medical groups providing breast imaging services. The core offering is FDA-approved advanced ultrasound (ABUS/photoacoustic) breast screening combined with AI-powered detection, positioned as an alternative to mammography for women with dense breast tissue and women under 40. The platform includes a patient portal (app.besoundbreast.com) for appointment booking and results viewing, a free Tyrer-Cuzick risk assessment tool, and operates physical locations in Los Angeles with mobile unit services coming soon. The company was founded in October 2025 by former NASA quantum physicist Bailey Renger and has raised $6.8M in seed funding.

Differentiator

Problem solved

Functional benefit

Products and services

  • BeSound Breast Imaging Radiation-free, pain-free 20-minute breast imaging scan using FDA-approved photoacoustic ultrasound combined with AI-powered detection, designed for women with dense breast tissue and women under 40, with results delivered in 24-48 hours through the patient dashboard.
  • BeSound Risk Assessment (Tyrer-Cuzick) Free, clinically validated Tyrer-Cuzick breast cancer risk quiz that calculates individualized 10-year and lifetime risk estimates and funnels higher-risk users into paid BeSound screening appointments.
  • BeSound Patient App & Web Portal Self-serve web application for booking appointments, completing intake and risk assessments, accessing scan results through a results dashboard, and managing waitlist and account activity.

Quantifiable outcome

  • Detects 35.7% more breast cancers than mammography alone
  • +7 more outcomes

Companies that use BeSound

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

BeSound technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

BeSound partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship, minor and core.

  • Muse Capital Optima ProgramflagshipStrategic or Co-development Partner · 8 April 2026BeSound was selected as one of ten women's health companies in Muse Capital's Optima Program — the first scalable health and performance platform designed for elite female athletes and sports executives, launched in partnership with Flywheel Ventures Group (providing technology) and the Red Bull Italy SailGP Team as part of SailGP's Impact League initiative. The program offers 360-degree physical and mental health support through science-backed solutions, positioning BeSound in the sports health ecosystem.
  • Red Bull Italy SailGP TeamminorStrategic or Co-development Partner · 8 April 2026Red Bull Italy SailGP Team is a partner in SailGP's Impact League initiative, collaborating with Muse Capital and Flywheel Ventures on the Optima Program that includes BeSound among its ten selected women's health companies. The partnership brings athletic performance expertise and sports science network to the women's health ecosystem.
  • Agape Medical Group, P.C.coreImplementation/ SI/ Consulting PartnerAgape Medical Group is a professional services corporation and provider partner that delivers clinical breast imaging services through BeSound's platform. Agape does not accept health insurance and operates on a self-pay model. BeSound provides the imaging technology and administrative platform; Agape provides licensed physicians, sonographers, and radiology reads.
  • Ian Grady, MD, FACScoreImplementation/ SI/ Consulting PartnerIan Grady MD FACS is a provider partner who accepts certain in-network insurance plans, offering an insurance-billed pathway for patients whose coverage is accepted. BeSound schedules patients with MD when they have accepted insurance. MD reads ultrasound images and provides clinical services.
  • Northern Valley Breast ClinicminorImplementation/ SI/ Consulting PartnerNorthern Valley Breast Clinic (NVBC) is referenced in the HIPAA Notice of Privacy Practice as a licensed physician and radiologist affiliate providing breast imaging interpretation services. Patients with accepted insurance through NVBC are directed to that provider's Notice of Privacy Practice.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

BeSound competitors and assessment

Company assessment

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers is a global medical imaging leader with mammography and ultrasound product lines. Comparable to BeSound as a broad incumbent in the breast imaging modality space with the resources to launch competing dense-breast screening offerings if the category gains traction.
  • Hologic: Hologic is the dominant incumbent in mammography (3D tomosynthesis) and broader women's health imaging and diagnostics. Comparable as the legacy breast imaging category leader whose installed base and hospital relationships represent the competitive incumbent against BeSound's DTC ultrasound offering.
  • GE HealthCare: GE HealthCare is a global medical imaging incumbent with a substantial mammography and women's health portfolio. Comparable as a broad incumbent whose R&D scale, distribution channels, and existing dense-breast screening offerings position it as the most credible large-scale competitive threat to BeSound.

Direct peers

  • Ezra: Ezra is a direct-to-consumer full-body MRI startup offering pay-out-of-pocket cancer and disease screening scans in retail locations. Highly comparable to BeSound in DTC premium imaging business model, retail location strategy, and self-pay price-transparent positioning targeting proactive health-conscious consumers.
  • QT Ultrasound: QT Ultrasound develops and operates FDA-cleared transmission ultrasound breast imaging as a radiation-free alternative to mammography. Directly comparable to BeSound as a breast ultrasound modality competitor focused on dense-breast and supplemental screening applications.
  • Delphinus Medical Technologies: Delphinus developed SoftVue, an FDA-cleared automated whole-breast ultrasound system for supplemental dense-breast screening. A modality peer to BeSound's photoacoustic ultrasound, targeting the same clinical gap in dense-breast cancer detection.
  • Prenuvo: Prenuvo is a DTC whole-body MRI screening startup emphasizing early cancer detection in a premium, wellness-oriented consumer experience. Closely comparable to BeSound on DTC imaging business model, premium self-pay pricing, retail storefront delivery, and proactive-health positioning for an affluent consumer base.

Emerging players

  • Neko Health: Neko Health is a DTC preventive body-scanning startup offering AI-augmented full-body imaging in a premium consumer retail experience. Comparable to BeSound in DTC premium imaging business model, AI-driven diagnostics, and consumer-brand-led approach to preventive screening.
  • iCAD: iCAD provides AI-powered breast imaging analytics (ProFound AI for DBT) and risk-stratification solutions used alongside mammography. Comparable to BeSound as a technology peer in AI-driven breast imaging interpretation, though operating as a vendor to incumbent imaging centers rather than a DTC operator.
  • SonoCiné: SonoCiné provides automated whole-breast ultrasound systems (AWBUS) deployed in clinics as a supplemental screening modality for dense breast tissue. Comparable to BeSound in targeting the dense-breast screening gap with ultrasound-based technology, though distributed through partner clinics rather than DTC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

BeSound social profiles

Digital presence

BeSound compliance and trust

Trust signal

Compliance1 record

BeSound financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BeSound leadership team

Management profile

Number of profiles

Profiles8 records

BeSound funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BeSound M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BeSound

What does BeSound do?

BeSound delivers radiation-free breast imaging using FDA-approved photoacoustic ultrasound (near-infrared light combined with traditional ultrasound) enhanced by AI-powered detection, sold direct-to-consumer at $350 per scan for women with dense breast tissue and women under 40. The platform also includes a free Tyrer-Cuzick breast cancer risk assessment, a self-serve patient web app for booking and results, and operates BeSound-branded retail locations in Los Angeles plus a forthcoming mobile van, while connecting patients with independent partner medical groups that provide licensed clinical interpretation.

Is BeSound a public or private company?

BeSound is a private company. It is classified as venture growth investor backed and is currently operating.

When was BeSound founded?

BeSound was founded in 2025. It employs 11 to 50 people.

Where is BeSound based?

BeSound is headquartered in Los Angeles, United States, in the North America region.

How does BeSound make money?

Three revenue lines are on record. Direct-to-Consumer Breast Imaging Scans are the primary driver. The others are insurance-Reimbursed Imaging and free Risk Assessment (Lead Generation).

Who are BeSound's main competitors?

Broad incumbents on record are Siemens Healthineers, Hologic and GE HealthCare. Direct peers are Ezra, QT Ultrasound, Delphinus Medical Technologies and Prenuvo. Emerging players are Neko Health, iCAD and SonoCiné.

Does BeSound have an API?

No public API is recorded for BeSound.

What industry is BeSound in?

BeSound's product category is Breast Imaging Services. Its primary akta.pro industry code is HLAFAJAJ, Women’s Imaging & Breast Health Centers, with a secondary code of HLAHABAD, Ultrasound & Echography Systems. Its NAICS code is 621512 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FortuneThree leaders on the biggest opportunities for AI in women’s healthAt Lux Capital's Health X Intelligence forum, a panel discussion featured three healthcare AI leaders—Angela Dao of Maven, Bailey Renger of BeSound, and Melissa Teran of Alife—sharing how their companies are integrating AI into women's health, including maternity care coordination, breast cancer ultrasound screening, and IVF embryo selection. The panelists highlighted both the significant potential of AI to improve women's health outcomes and concerns about patients using general AI tools like ChatGPT to self-diagnose outside clinical settings, with Dao warning that untuned LLMs may be adding to patient anxiety rather than providing accurate guidance.Healthcare BrewStartup BeSound seeks to reduce breast cancer in young womenBeSound, founded by Bailey Renger, launched on Sept. 30 with $6.8 million in seed funding to provide breast cancer screening for young women. The startup offers 20-minute radiation-free scans with results in 24-48 hours for $350, aiming to reduce late-stage diagnoses. Renger plans to expand nationwide and lower costs to $150.Radiology BusinessBreast imaging startup BeSound raises $7M, eyes nationwide clinic rolloutBreast imaging startup BeSound has raised nearly $7 million in seed funding to support a nationwide rollout of its healthcare clinics. The company plans to open its first location in West Hollywood this fall, with additional sites planned for New York and other areas in the coming months.StartupsunionBeSound Raises $6.8M: Revolutionary Femtech Startup Transforms Global Breast Cancer Screening InfrastructureBeSound, a San Francisco-based femtech startup founded by former NASA quantum researcher Bailey Renger, has raised $6.8M in seed funding co-led by Overwater Ventures, Kindred Ventures, and Muse Capital to expand its FDA-approved photoacoustic ultrasound breast screening platform. The funding will support clinical location expansion starting with West Hollywood and New York, enabling direct-to-consumer breast cancer screening at $350 per scan for the 40%+ of women with dense breast tissue who face high mammography failure rates. The company reports its technology achieves a 75% reduction in unnecessary biopsies while maintaining hospital-grade diagnostic precision.